van der Pal HJ - Search Results

1

Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function.

van der Kooi ALF, van Dijk M, Broer L, van den Berg MH, Laven JSE, van Leeuwen FE, Lambalk CB, Overbeek A, Loonen JJ, van der Pal HJ, Tissing WJ, Versluys B, Bresters D, Beerendonk CCM, Ronckers CR, van der Heiden-van der Loo M, Kaspers GL, de Vries ACH, Robison LL, Hudson MM, Chemaitilly W, Byrne J, Berger C, Clemens E, Dirksen U, Winther JF, Fosså SD, Grabow D, Haupt R, Kaiser M, Kepak T, Kruseova J, Modan-Moses D, Pluijm SMF, Spix C, Zolk O, Kaatsch P, Krijthe JH, Kremer LC, Yasui Y, Brooke RJ, Uitterlinden AG, van den Heuvel-Eibrink MM, van Dulmen-den Broeder E. van der Kooi ALF, et al. Among authors: van den heuvel eibrink mm, van der heiden van der loo m, van der pal hj, van leeuwen fe, van dulmen den broeder e, van dijk m, van den berg mh. Hum Reprod. 2021 Mar 18;36(4):1120-1133. doi: 10.1093/humrep/deaa342. Hum Reprod. 2021. PMID: 33582778 Free PMC article.

2

Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review.

Kremer LC, van der Pal HJ, Offringa M, van Dalen EC, Voûte PA. Kremer LC, et al. Among authors: van der pal hj, van dalen ec. Ann Oncol. 2002 Jun;13(6):819-29. doi: 10.1093/annonc/mdf167. Ann Oncol. 2002. PMID: 12123328 Free article. Review.

3

Cumulative incidence and risk factors of mitoxantrone-induced cardiotoxicity in children: a systematic review.

van Dalen EC, van der Pal HJ, Bakker PJ, Caron HN, Kremer LC. van Dalen EC, et al. Among authors: van der pal hj. Eur J Cancer. 2004 Mar;40(5):643-52. doi: 10.1016/j.ejca.2003.12.006. Eur J Cancer. 2004. PMID: 15010064 Review.

4

Risk of morbidity and mortality from cardiovascular disease following radiotherapy for childhood cancer: a systematic review.

van der Pal HJ, van Dalen EC, Kremer LC, Bakker PJ, van Leeuwen FE. van der Pal HJ, et al. Among authors: van dalen ec, van leeuwen fe. Cancer Treat Rev. 2005 May;31(3):173-85. doi: 10.1016/j.ctrv.2005.03.008. Cancer Treat Rev. 2005. PMID: 15896910 Review.

5

Clinical heart failure during pregnancy and delivery in a cohort of female childhood cancer survivors treated with anthracyclines.

van Dalen EC, van der Pal HJ, van den Bos C, Kok WE, Caron HN, Kremer LC. van Dalen EC, et al. Among authors: van den bos c, van der pal hj. Eur J Cancer. 2006 Oct;42(15):2549-53. doi: 10.1016/j.ejca.2006.04.014. Epub 2006 Aug 17. Eur J Cancer. 2006. PMID: 16919450

6

Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study.

van Dalen EC, van der Pal HJ, Kok WE, Caron HN, Kremer LC. van Dalen EC, et al. Among authors: van der pal hj. Eur J Cancer. 2006 Dec;42(18):3191-8. doi: 10.1016/j.ejca.2006.08.005. Epub 2006 Sep 20. Eur J Cancer. 2006. PMID: 16987655

7

Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy.

van Dalen EC, van der Pal HJ, Caron HN, Kremer LC. van Dalen EC, et al. Among authors: van der pal hj. Cochrane Database Syst Rev. 2006 Oct 18;(4):CD005008. doi: 10.1002/14651858.CD005008.pub2. Cochrane Database Syst Rev. 2006. PMID: 17054232 Updated. Review.

8

Medical assessment of adverse health outcomes in long-term survivors of childhood cancer.

Geenen MM, Cardous-Ubbink MC, Kremer LC, van den Bos C, van der Pal HJ, Heinen RC, Jaspers MW, Koning CC, Oldenburger F, Langeveld NE, Hart AA, Bakker PJ, Caron HN, van Leeuwen FE. Geenen MM, et al. Among authors: van den bos c, van der pal hj, van leeuwen fe. JAMA. 2007 Jun 27;297(24):2705-15. doi: 10.1001/jama.297.24.2705. JAMA. 2007. PMID: 17595271

9

Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma.

De Bruin ML, Dorresteijn LD, van't Veer MB, Krol AD, van der Pal HJ, Kappelle AC, Boogerd W, Aleman BM, van Leeuwen FE. De Bruin ML, et al. Among authors: van der pal hj, van t veer mb, van leeuwen fe. J Natl Cancer Inst. 2009 Jul 1;101(13):928-37. doi: 10.1093/jnci/djp147. Epub 2009 Jun 17. J Natl Cancer Inst. 2009. PMID: 19535773

10

Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy.

van Dalen EC, van der Pal HJ, Caron HN, Kremer LC. van Dalen EC, et al. Among authors: van der pal hj. Cochrane Database Syst Rev. 2009 Oct 7;(4):CD005008. doi: 10.1002/14651858.CD005008.pub3. Cochrane Database Syst Rev. 2009. PMID: 19821337 Updated. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

186 results

Search Page